Yorkville Advisors

Plug Power Inc. is a leading provider of hydrogen fuel cell solutions, focusing on clean and zero-emission technologies for electric mobility and stationary power markets in North America and Europe. The company specializes in proton exchange membrane (PEM) fuel cell systems, fuel processing technologies, and hybrid solutions, alongside the necessary hydrogen storage and dispensing infrastructure. Its products include GenDrive, a hydrogen-powered PEM fuel cell system for material handling vehicles; GenFuel, which encompasses hydrogen delivery and dispensing; GenCare, a maintenance program for its fuel cell systems; and GenSure, a stationary fuel cell solution for backup and grid-support power. Plug Power also offers the GenKey solution, which integrates all essential components for fuel cell power, and ProGen, a fuel cell stack technology used in various applications. With over 40,000 deployed fuel cell systems, Plug Power is a significant player in the hydrogen economy and has established a network of hydrogen highways across North America. Founded in 1997 and headquartered in Latham, New York, the company serves a diverse clientele, including major corporations and industries.

Vivoryon Therapeutics AG is a clinical stage biopharmaceutical company based in Halle, Germany, specializing in the research and development of therapeutic products for Alzheimer's disease and cancer. The company's lead candidate, PQ912, is a small molecule QC inhibitor that has completed Phase IIb clinical trials for Alzheimer's disease and is also being explored for cancer treatment. Additionally, Vivoryon is developing PQ1565, a small molecule inhibitor targeting glutaminyl-peptide cyclotransferase-like for cancer therapy, along with a monoclonal antibody aimed at enhancing the clearance of toxic pyroglutamate-Abeta. The company collaborates with various institutions, including the University Medical Center Schleswig-Holstein and Nordic Bioscience, to advance its clinical and research initiatives. Originally founded in 1997 as Probiodrug AG, the company rebranded to Vivoryon Therapeutics AG in June 2019.

Lytus Technologies Holdings is a platform services company based in India that specializes in content streaming and telecasting services. In addition to its core offerings, the company provides telemedicine services, facilitated by local health centers to enhance accessibility to healthcare. Lytus connects its customers through customer premises equipment (CPE) devices, such as set-top boxes (STBs), ensuring a comprehensive range of services that includes both entertainment and health-related solutions. Its extensive customer base and strong market presence allow Lytus to diversify its product portfolio effectively, catering to a wide array of consumer needs.

Quantum Corp. is a global specialist in backup, recovery, and archive solutions trusted by over 50,000 customers worldwide. Their best-of-breed, open systems platforms, including DXi-Series for fast backup and restore, Scalar for disaster recovery and data retention, and StorNext for high-performance file sharing and archiving, offer significant storage efficiencies and cost savings while minimizing risk. Quantum helps businesses of all sizes address their data protection, retention, and management challenges with scalable and efficient solutions.

Kraig Biocraft Laboratories, Inc. is a biotechnology company based in Ann Arbor, Michigan, established in 2006. The company specializes in the development of high-performance fibers through recombinant DNA technology, targeting applications in the textile, specialty fiber, and technical textile industries. Kraig Biocraft focuses on creating innovative products that address practical challenges in these markets. Notable offerings include Monster Silk, which utilizes the natural elasticity of spider silk to produce a more flexible fiber than conventional silk, and Dragon Silk, which enhances Monster Silk's properties with additional strength elements from native spider silk. Through its research and development efforts, Kraig Biocraft aims to commercialize advanced textiles and high-strength fibers, addressing the growing demand for innovative materials.

FibroBiologics, based in Houston, Texas, is a clinical-stage regenerative medicine company that specializes in developing fibroblast-based therapies aimed at treating chronic diseases with significant unmet medical needs. The company is focused on various conditions, including degenerative disc disease, multiple sclerosis, wound healing, and certain cancers, as well as exploring applications related to extending life through thymic and splenic involution reversal. FibroBiologics holds over 150 patents and patents pending in the U.S. and internationally, covering diverse clinical pathways. The company is positioned at the forefront of medical advancement in cell therapy, offering innovative solutions to improve patient outcomes in challenging health conditions.

Northwest Biotherapeutics, Inc. is a biotechnology company based in Bethesda, Maryland, focused on developing personalized immune therapies for cancer. Founded in 1996, the company utilizes its proprietary DCVax platform, which leverages activated dendritic cells to stimulate the patient's immune system to target and attack cancer cells. Northwest Biotherapeutics is advancing several product candidates, including DCVax-L, currently in Phase III clinical trials for glioblastoma multiforme, and DCVax-Direct, in Phase I/II trials for various inoperable solid tumors. The company aims to offer effective cancer treatments that not only extend survival and time to recurrence but also enhance the quality of life for patients with minimal side effects compared to traditional therapies.

Baijiayun is a Chinese company specializing in cloud-based audio and video technology solutions for various sectors, including education, finance, healthcare, and government. It offers a comprehensive suite of products such as live broadcast services, on-demand video, dual-teacher classrooms, and online training systems. The company also provides advanced solutions incorporating video AI and smart learning technologies, catering to a wide range of applications, from large-scale open classes to internal corporate training and online conferences. Baijiayun is recognized for its extensive intellectual property portfolio and core technologies, positioning it as a leader in the video technology market within China, with a focus on facilitating innovation and expansion for enterprises through its one-stop service offerings.

Armlogi Holding Corp is a U.S.-based logistics company specializing in warehouse management and order fulfillment for cross-border e-commerce merchants targeting the U.S. market. It operates twelve modern warehouses, totaling 2.5 million square feet, adhering to ISO 9001 quality standards. These facilities are equipped with advanced technology and specialized equipment to handle large and bulky items efficiently and securely. Armlogi's comprehensive services include customs brokerage, transportation to U.S. warehouses, and order fulfillment.

Powell Max Limited is a financial printing and communication services company that specializes in providing financial communication and printing services. The company focuses on producing essential financial documents, such as initial public offering prospectuses, which serve as key communication tools between issuers and investors. Their services include meticulous typesetting and preparation of these documents for primary market customers.

Powell Max Limited is a financial printing and communication services company that specializes in providing financial communication and printing services. The company focuses on producing essential financial documents, such as initial public offering prospectuses, which serve as key communication tools between issuers and investors. Their services include meticulous typesetting and preparation of these documents for primary market customers.

Soluna Holdings specializes in developing green data centers powered by wasted renewable energy, primarily serving the blockchain industry. The company focuses on batchable computing tasks like cryptocurrency mining and high-density computations. By vertically integrating renewable power generation with blockchain computing facilities, Soluna aims to mine cryptocurrencies more cheaply and sustainably than traditional methods. Their mission is to power the crypto-economy with clean, low-cost renewable energy by building a self-contained, distributed, scalable infrastructure for blockchain operations.

Brand Engagement Network is an advertising company that specialises in conversational AI interfaces, consumer engagement, and digital assistance, providing human-like interactions and safe environments through multi-modal communication. Its mission is to create the best AI Assistants, making them helpful, creative, clever, and friendly. With a vision to empower people and shape the future of intelligent digital assistants.

ImmunoPrecise Antibodies Ltd. is a biotherapeutic research and technology company specializing in the production of custom antibodies and related services. Headquartered in Fargo, North Dakota, the company operates in the United States, Canada, Europe, and internationally. Its extensive service offerings include B cell sorting, phage display production, transgenic animal models, and various antibody engineering techniques. The company has developed a reputation for its advanced capabilities in antibody discovery and development, leveraging systems biology, multi-omics modeling, and artificial intelligence to enhance efficiency and accuracy. ImmunoPrecise Antibodies engages in collaborations with academic and research institutions, including partnerships aimed at developing antibody-based tests for COVID-19 and neutralizing antibodies against SARS-CoV-2. Founded in 1989, the company continues to contribute to the advancement of novel biologics and therapeutic solutions for challenging diseases.

Wearable Devices Ltd. is an innovative company based in Kiryat Tivon, Israel, specializing in the development and manufacture of touch-free wearable controllers for digital devices under the brand name Mudra. Founded in 2014, the company has created a non-invasive neural input interface technology in the form of a wristband that allows users to control various digital devices, including smartphones, smartwatches, AR glasses, and VR headsets, through subtle finger movements and hand gestures without physical contact. The Mudra platform integrates proprietary sensors and artificial intelligence algorithms, enabling seamless interaction in both Business-to-Business and Business-to-Consumer markets. Notable products include Mudra Inspire, a band designed for the Apple Watch that facilitates touchless operation of devices within the Apple ecosystem. Wearable Devices Ltd. aims to establish a new standard for input interfaces in the evolving landscape of augmented and virtual reality.

NioCorp Developments Ltd., established in 1987 and headquartered in Centennial, Colorado, is a mineral exploration and development company focused on North America. It specializes in the exploration and development of mineral deposits, with a primary focus on the Elk Creek niobium/scandium/titanium project located in Southeastern Nebraska. This project is notable for being the highest-grade niobium project under development in North America and the second-largest indicated or rare earth mineral resource in the United States. NioCorp's planned products, including niobium, scandium, titanium, and magnetic rare earths, are all designated as critical by the U.S. government and play vital roles in clean technologies and the global energy transition.

Zapp is a UK company that designs, manufactures and sells high performance electric vehicles. Our founders are automotive professionals from all over the world who share a commitment to sustainability, a long passion for electric vehicles, motorcycles, and believe in the choice of personal urban mobility. In 2017, we assembled a team of talented designers and engineers to help us realize this vision to design and manufacture electric vehicles. Superbike Performance. Scooter Accessible. Simply Electric. No Compromise.

Scilex Holding Co is a pharmaceutical company specializing in acquiring and commercializing late-stage prescription products focused on non-opioid pain management. Its primary product, ZTlido, is a topical lidocaine system used to relieve nerve pain associated with postherpetic neuralgia. Additionally, Scilex is developing Gloperba, an oral colchicine solution for preventing painful gout flares in adults. The company's pipeline includes SP-102, a viscous gel formulation of a corticosteroid for epidural injections, and SP-103, a Phase 2 triple-strength capsaicin cream for neuropathic pain.

Cardio Diagnostics is a biotechnology company focused on enhancing the prevention and early detection of cardiovascular disease through advanced technology. Founded in 2017 and based in Coralville, Iowa, the company leverages machine learning and artificial intelligence, along with DNA-based solutions, to offer personalized and precise healthcare options. Cardio Diagnostics aims to develop and commercialize its proprietary integrated Genetic-Epigenetic Engine, which is designed to facilitate improved prevention, early detection, and treatment assistance for cardiovascular conditions. Through its innovative approach, Cardio Diagnostics seeks to become a leader in medical technology for cardiovascular health.

Kraig Biocraft Laboratories, Inc. is a biotechnology company based in Ann Arbor, Michigan, established in 2006. The company specializes in the development of high-performance fibers through recombinant DNA technology, targeting applications in the textile, specialty fiber, and technical textile industries. Kraig Biocraft focuses on creating innovative products that address practical challenges in these markets. Notable offerings include Monster Silk, which utilizes the natural elasticity of spider silk to produce a more flexible fiber than conventional silk, and Dragon Silk, which enhances Monster Silk's properties with additional strength elements from native spider silk. Through its research and development efforts, Kraig Biocraft aims to commercialize advanced textiles and high-strength fibers, addressing the growing demand for innovative materials.

Faraday Future is a design and technology company focused on revolutionizing the transportation sector through innovative solutions. The company aims to address the evolving needs of consumers by integrating advancements in energy, artificial intelligence, and shared mobility. By blurring the lines between the automotive industry and technology sectors, Faraday Future seeks to create a global ecosystem that redefines transportation, content, and vehicle ownership. Their approach reflects a response to modern challenges such as urban congestion and changing lifestyles, emphasizing a commitment to developing vehicles that align with contemporary demands.

NioCorp Developments Ltd., established in 1987 and headquartered in Centennial, Colorado, is a mineral exploration and development company focused on North America. It specializes in the exploration and development of mineral deposits, with a primary focus on the Elk Creek niobium/scandium/titanium project located in Southeastern Nebraska. This project is notable for being the highest-grade niobium project under development in North America and the second-largest indicated or rare earth mineral resource in the United States. NioCorp's planned products, including niobium, scandium, titanium, and magnetic rare earths, are all designated as critical by the U.S. government and play vital roles in clean technologies and the global energy transition.

Kinarus AG is a biopharmaceutical company based in Basel, Switzerland, focused on developing innovative medicines targeting stress-related inflammatory processes. The company employs a cross-disease area approach to assess therapeutic targets, aiming to create differentiated treatments that address unmet medical needs. By leveraging its expertise in biopharmaceutical development, Kinarus AG strives to contribute to improved health outcomes in patients suffering from various inflammatory conditions.

D-Wave Systems Inc. is a pioneering company in the field of quantum computing, recognized as the world’s first commercial supplier of quantum computers. Founded in 1999 and headquartered in Burnaby, Canada, D-Wave specializes in the development, fabrication, and integration of superconducting quantum computers. The company offers a range of products, including the D-Wave Two System, a commercial quantum computer, and D-Wave Hybrid, an open-source platform for creating hybrid quantum-classical applications. Leap, its cloud-based service, provides real-time access to quantum computing resources along with development tools and educational content. D-Wave’s quantum computers are applied across various sectors, addressing challenges in mission planning, logistics, machine learning, and optimization problems, among others. The company serves diverse industries, including defense, finance, energy, and academia, and also offers professional services, training, and customer support to enhance user experience and application development.

Canoo is a mobility technology company that specializes in developing electric vehicles designed to transform the automotive industry through innovative design and technology. The company has created a proprietary modular electric vehicle platform that maximizes interior space and can be adapted for various applications, catering to both consumer and commercial markets. With a focus on serving commercial fleets, government, and military customers, Canoo aims to deliver new products efficiently and cost-effectively, allowing for rapid iteration and addressing diverse use cases. The company's experienced team, comprised of over 350 professionals from leading technology and automotive sectors, drives its mission to prioritize customer needs and redefine vehicle ownership models.

Virgin Orbit, LLC is a vertically integrated space company based in Long Beach, California, and incorporated in 2016. As a subsidiary of Virgin.com Limited, it specializes in providing dedicated launch services for small satellites, catering to both commercial and government entities. The company operates the LauncherOne system, which offers flexible launch capabilities tailored specifically for small satellites. Virgin Orbit’s services encompass the delivery of satellites into orbit for a range of customers across various sectors, including commercial, civil, and national security. By focusing on democratizing access to space, Virgin Orbit aims to enhance opportunities for research, private astronaut flights, and satellite deployment, ultimately benefiting life on Earth.

Bird is a micro-mobility company that specializes in designing a vehicle-sharing platform focused on providing affordable and sustainable transportation solutions. The platform facilitates access to shared personal electric vehicles, including e-scooters and electric bicycles, which can be easily picked up and dropped off at various locations. By collaborating with cities, Bird aims to enhance urban mobility, reduce car trips, alleviate traffic congestion, and lower carbon emissions. Operating in multiple locations, including over ten cities in Canada, Bird emphasizes accessibility and environmentally friendly transport options, appealing to communities seeking reliable alternatives to traditional motor vehicles.

Kraig Biocraft Laboratories, Inc. is a biotechnology company based in Ann Arbor, Michigan, established in 2006. The company specializes in the development of high-performance fibers through recombinant DNA technology, targeting applications in the textile, specialty fiber, and technical textile industries. Kraig Biocraft focuses on creating innovative products that address practical challenges in these markets. Notable offerings include Monster Silk, which utilizes the natural elasticity of spider silk to produce a more flexible fiber than conventional silk, and Dragon Silk, which enhances Monster Silk's properties with additional strength elements from native spider silk. Through its research and development efforts, Kraig Biocraft aims to commercialize advanced textiles and high-strength fibers, addressing the growing demand for innovative materials.

Virgin Orbit, LLC is a vertically integrated space company based in Long Beach, California, and incorporated in 2016. As a subsidiary of Virgin.com Limited, it specializes in providing dedicated launch services for small satellites, catering to both commercial and government entities. The company operates the LauncherOne system, which offers flexible launch capabilities tailored specifically for small satellites. Virgin Orbit’s services encompass the delivery of satellites into orbit for a range of customers across various sectors, including commercial, civil, and national security. By focusing on democratizing access to space, Virgin Orbit aims to enhance opportunities for research, private astronaut flights, and satellite deployment, ultimately benefiting life on Earth.

Xos Trucks Inc. is an electric mobility company specializing in the development of electric commercial vehicle fleets and battery-electric vehicle platforms. Founded in 2016 and based in North Hollywood, California, Xos focuses on medium- and heavy-duty vehicles designed for last-mile delivery routes, typically under 200 miles per day. The company aims to assist commercial fleets in transitioning from diesel to zero-emission electric vehicles, offering similar performance with lower operating costs. Xos Trucks also designs electrified armored vehicles and delivers its products to markets in Texas and Illinois, with plans to expand to Michigan and New Jersey. Leveraging proprietary technologies, Xos provides fleets with vehicles that are not only environmentally friendly but also more efficient and easier to maintain compared to traditional internal combustion engine vehicles.

Romeo Power, Inc. is an energy technology company specializing in the design and manufacture of lithium-ion battery modules and packs specifically for commercial electric vehicles. Founded in 2015 and headquartered in Vernon, California, the company aims to facilitate sustainable transportation by offering energy-dense battery systems that provide superior performance, including enhanced acceleration, extended range, and improved safety. Romeo Power's product lineup includes Hermes modules tailored for trucks and buses, and the Brown Recluse, a passive cooling system that optimizes heat transfer and can be integrated into various vehicle configurations. The company’s solutions are customizable and scalable, supported by a proprietary battery management system that enhances the longevity and efficiency of its battery offerings.

Kraig Biocraft Laboratories, Inc. is a biotechnology company based in Ann Arbor, Michigan, established in 2006. The company specializes in the development of high-performance fibers through recombinant DNA technology, targeting applications in the textile, specialty fiber, and technical textile industries. Kraig Biocraft focuses on creating innovative products that address practical challenges in these markets. Notable offerings include Monster Silk, which utilizes the natural elasticity of spider silk to produce a more flexible fiber than conventional silk, and Dragon Silk, which enhances Monster Silk's properties with additional strength elements from native spider silk. Through its research and development efforts, Kraig Biocraft aims to commercialize advanced textiles and high-strength fibers, addressing the growing demand for innovative materials.

Lordstown Motors is an automotive company focused on the development and manufacture of light-duty electric trucks aimed at fleet customers. The company operates engineering, research, and development facilities located in Farmington Hills, Michigan, and Irvine, California. Its flagship vehicle, the Endurance, is an all-electric pickup truck that is currently in the final design and testing phase at its facility in Lordstown, Ohio. As of now, the company has not yet launched a completed product to the market.

NLS Pharma is a clinical-stage drug development company focusing on neurobehavioral and neurocognitive disorders and their pharmacognosia. Its patient-centered approach increases the rate for success and our successful collaboration with experts across industry, academia allows for a target specific and customized approach.

Curetis AG is a Germany-based company that specializes in developing molecular diagnostics solutions for infectious diseases. Founded in 2015 and now operating as a subsidiary of OpGen, Inc., Curetis focuses on the detection of pathogens and antibiotic resistance markers. The company offers a rapid diagnostic platform that enables multiparameter testing of various analytes in a single run, providing comprehensive panels for detecting a wide range of pathogens and resistance genes. This innovative approach aims to improve patient outcomes by delivering early, actionable information to healthcare providers, particularly in the context of severe bacterial infections. Curetis's technology not only addresses current healthcare challenges but also presents opportunities for future expansions into other clinical applications beyond infectious diseases.

Curetis AG is a Germany-based company that specializes in developing molecular diagnostics solutions for infectious diseases. Founded in 2015 and now operating as a subsidiary of OpGen, Inc., Curetis focuses on the detection of pathogens and antibiotic resistance markers. The company offers a rapid diagnostic platform that enables multiparameter testing of various analytes in a single run, providing comprehensive panels for detecting a wide range of pathogens and resistance genes. This innovative approach aims to improve patient outcomes by delivering early, actionable information to healthcare providers, particularly in the context of severe bacterial infections. Curetis's technology not only addresses current healthcare challenges but also presents opportunities for future expansions into other clinical applications beyond infectious diseases.

Q BioMed Inc. is a biomedical acceleration and development company based in New York, founded in 2013. The company specializes in licensing and acquiring undervalued biomedical assets, providing strategic resources, developmental support, and capital to maximize their potential. Q BioMed is focused on enhancing therapeutic options in the life sciences and healthcare sectors. Its product offerings include Strontium Chloride SR89 and Metastron, both radiopharmaceuticals aimed at alleviating pain from bone cancer. Additionally, the company is developing several other candidates, such as Man-01 for primary open-angle glaucoma, QBM-001 for rare pediatric non-verbal autism spectrum disorder, and Uttroside-B for liver cancer. Q BioMed has also partnered with Mannin Research to develop novel therapeutics for Covid-19.

Future Farm Technologies Inc is an indoor plant growth technology company specializing in innovative solutions for vertical farming and LED lighting. The company focuses on enhancing agricultural productivity by utilizing advanced technologies to optimize plant growth in controlled environments. In addition to its core business in indoor farming, Future Farm also operates an ornamental plant greenhouse, contributing to its revenue primarily through the sale of nursery plants. The company is dedicated to providing sustainable food options with a focus on protein-rich products.

The largest taxi cab company doesn’t own a single car, the largest hotel has no real estate and the biggest restaurateur doesn’t run a single kitchen. MOI aims to be the largest “Spa/Salon”, “Barbershops” “Beauty” providers in the world without any rent, employees nor overhead. OpenTable & Grubhub Combined for the Beauty Industry; Browse, Book, Pay and Rate with the Swipe of a finger.MOI is an app allowing to connect in one place all the qualified spas salons and barbershops as well as freelance qualified and vetted artists and consumers. MOI is an online booking aggregator of hair spa and beauty services that connects salons barbershops nail salons, etc... looking for customers with customers looking for grooming locations or at home services. MOI is about to launch in New York City in August 2017 . MOI is looking forward to launching in more cities in the coming year. MOI Inc. expects to launch its smart phone app allowing individuals to identify and book beauty services while conveniently identifying the specific services needed, whether it’s is a full service shaving, hair and makeup by either a professional coming to them, or at any salon or barbershops in any given geographical area, starting with NY Metro as our launching market with more than 18,000 salons and 2,000 barbershops. The “MOI” App is effortless to use, exciting and necessary. We aim to benefit both providers on the app, as well as our subscribers to become the “go – to” platform for beauty and grooming services. The company is currently only focusing on the New York market and intend to be the principal app for the entire industry. in addition the company has a (point of sale) POS that is given for free to all salons interested in having a highly efficient system, this is the only develloped by a cosmetologist Elana B, understandng the indsurty needs, the POS created is allowing to save money on receptionists and making them true hosts, as well as managing the calendar, inventory, employees, and synchronizing all for free with the app increasing bookings by 25% on average. MOI is an ambitious and advanced system taking into account (B2B needs) and B2C requirements, with qualified providers. the Only booking app rewarding exising loyal clients and exposing providers to new customers daily. MOI is an outlier of all the companies out there because it was created and envisioned by an insider to the industry Elana B, contrary to all the other platform that are created by individuals that do not understand the needs of the providers and their relationships to their customers.Nor really understand that clients need taillored services and obejctive reviews.

Medivie Therapeutic Limited is a company based in Hemel Hempstead, United Kingdom, established in 2012 by Anthony Lovat. The company specializes in the development and marketing of dental support devices (DSD) for various medical applications. Its notable product, Laboraide, is designed to be used during childbirth, easing pain and potentially reducing labor time by promoting relaxation of jaw, neck, and head muscles. Additionally, Medivie is developing modular pacifiers aimed at enhancing mouth structure and preventing future dental issues in children. The company's products also target migraine relief, chronic pain management, and cognitive enhancement. Medivie distributes its offerings through a network of distributors and online platforms across Asia, Latin America, the United States, Europe, and Canada. Joshua Rurka currently leads the company, building on the extensive research and development experience from its founding association with the OPRO Group, a recognized leader in customized dental protectors.

Neomedia Technologies Inc is a U.S.-based company specializing in the development of two-dimensional (2D) mobile barcode technology and services. The company focuses on enabling print and broadcast media to engage interactively with their audiences through the use of 2D barcodes, which simplify access to content by bypassing long URLs and cumbersome menus. Neomedia's solutions transform mobile devices with cameras into barcode scanners, facilitating a variety of applications in mobile marketing and commerce. By providing the necessary tools and infrastructure, Neomedia supports wireless carriers, brands, mobile phone manufacturers, and media companies in creating a reliable and universal optical messaging ecosystem, enhancing consumer engagement and delivering real-time content that users can easily carry on their mobile devices.

Oasmia Pharmaceutical AB specializes in the development and commercialization of innovative drugs for human and veterinary oncology, primarily in Sweden. The company focuses on creating novel formulations based on established cytostatics, aimed at enhancing efficacy and reducing side effects compared to existing treatments. Oasmia's portfolio includes Apealea/Paclical, which has completed phase III clinical trials for ovarian cancer, and Docetaxel micellar, a patented formulation in pre-clinical stages for prostate cancer. Additionally, it offers Doxophos, a formulation of doxorubicin used for various cancers, and KB9520, which is in pre-clinical development to mitigate side effects of cytostatic treatments. In the veterinary sector, Oasmia markets Paccal Vet and Doxophos Vet for mammary carcinoma and lymphoma, respectively. The company also possesses proprietary technologies, including XR-17, which enhances solubility for oncology applications. Founded in 1988 and headquartered in Uppsala, Sweden, Oasmia Pharmaceutical is committed to advancing cancer treatment through its research in nanotechnology and patented formulations.

Neomedia Technologies Inc is a U.S.-based company specializing in the development of two-dimensional (2D) mobile barcode technology and services. The company focuses on enabling print and broadcast media to engage interactively with their audiences through the use of 2D barcodes, which simplify access to content by bypassing long URLs and cumbersome menus. Neomedia's solutions transform mobile devices with cameras into barcode scanners, facilitating a variety of applications in mobile marketing and commerce. By providing the necessary tools and infrastructure, Neomedia supports wireless carriers, brands, mobile phone manufacturers, and media companies in creating a reliable and universal optical messaging ecosystem, enhancing consumer engagement and delivering real-time content that users can easily carry on their mobile devices.

Medicago Inc. is a biotechnology company headquartered in Quebec City, Canada, specializing in the research, development, and commercialization of vaccines. The company employs proprietary plant-based manufacturing and virus-like particle (VLP) technologies to create innovative vaccines and therapeutics for infectious diseases. Its notable product candidates include a VLP vaccine for the H5N1 pandemic influenza, which has successfully completed Phase I clinical trials, as well as an H1N1 VLP vaccine aimed at the Influenza A/California/04/09 virus and various seasonal influenza vaccines. Medicago has established collaboration agreements with organizations such as Viridis S.A. and Genopole biopark for the production of pandemic and seasonal influenza vaccines, alongside a partnership with Philip Morris International for developing a therapeutic protein with a human-compatible glycosylation pattern. Founded in 1997, Medicago is dedicated to addressing emerging public health challenges through its advanced vaccine technologies.

Resverlogix Corp. is a late-stage clinical biotechnology company based in Calgary, Canada, focused on developing innovative therapeutics for cardiovascular diseases and related conditions. The company's lead product, apabetalone, is a first-in-class small molecule that selectively inhibits the bromodomain and extra-terminal (BET) proteins, targeting the second bromodomain to influence disease-causing genes. Apabetalone is currently undergoing Phase III clinical trials for various indications, including cardiovascular disease, chronic kidney disease, and neurodegenerative disorders. In addition to apabetalone, Resverlogix is advancing several development programs, including NexVas technologies aimed at plaque regression and vascular inflammation, as well as therapeutic candidates for Alzheimer's disease and fibrotic conditions. The company's research underscores its commitment to addressing significant unmet medical needs through innovative biopharmaceutical solutions.

WILEX a biopharmaceutical company, develops drugs and diagnostic agents to detect cancer, treat malignant tumours, and prevent metastases. Its product line includes RENCAREX, a phase III substance for the treatment of non-metastatic renal cell cancer; REDECTANE, a phase III substance for the treatment of renal mass; and MESUPRON, a phase II substance for the treatment of pancreatic and breast cancer. The company's products also comprise the MEK inhibitor WX-554, which is under Phase I clinical trial; and the other oncology projects, including PI3K inhibitor WX-037 and three antibody programmes under preclinical development. It has a strategic alliance with UCB Pharma S.A. to develop preclinical oncology portfolio. The company was founded in 1997 and is headquartered in Munich, Germany.

Allon Therapeutics Inc. is a clinical-stage biotechnology company based in Vancouver, Canada, specializing in the development of therapies for central nervous system disorders. The company's lead product, Davunetide, is an intranasal drug currently undergoing Phase IIa clinical trials for the treatment of Alzheimer's disease, cognitive impairment related to schizophrenia, and frontotemporal dementia. In addition, Allon is evaluating an intravenous formulation of Davunetide for patients who have undergone coronary artery bypass surgery. The company also has a preclinical drug candidate, AL-309, which has shown promise in animal models for conditions such as peripheral neuropathy and fetal alcohol syndrome. Allon Therapeutics collaborates with several research institutions, including the National Institute of Aging and the Alzheimer's Disease Cooperative Study, to advance its drug development efforts. The company was previously known as Neuro Discovery Inc. before rebranding in 2004.

Mobile Max Technologies Ltd is a technology company based in Tel Aviv, Israel, specializing in the development and licensing of unified communication (UC) solutions and mobile least cost routing technology. Founded in 2004, Mobile Max provides a comprehensive suite of services to service providers, carriers, and IP/PBX providers. Its flagship product, the MobileMax UC Suite, enables carriers to offer mobile UC applications that facilitate various communication functions such as business and private calling, remote office capabilities, call forwarding, conference calling, and mobile VoIP solutions. Additionally, the company offers the MobileMax Server, a provisioning tool that customizes applications according to clients' needs and delivers them directly to users' mobile devices. Through its innovative technology, Mobile Max aims to enhance communication efficiency for its clients.

Ashford Hospitality Trust is a real estate investment trust (REIT) that specializes in the hospitality sector, focusing primarily on full-service upscale and upper-upscale hotel properties across the United States. The company operates through its subsidiary, Ashford Hospitality Limited Partnership, which manages its assets. Ashford's business encompasses direct hotel investments, achieved through both acquisitions and new developments, as well as hotel financing, which involves owning subordinate hotel-related mortgages. The properties owned by Ashford operate under well-known brands such as Marriott, Hilton, Hyatt, Crowne Plaza, and Sheraton. In addition to its core hotel investments, Ashford provides real estate investment services, including mezzanine financing, first mortgage financing, and sales-leaseback transactions.

Hybrigenics Pharma is a bio-pharmaceutical company specializing in researching and developing new targets and therapies for cancer treatment. Their focus lies in studying Deubiquitinating Enzymes (DUBs) and the potential of patented DUB inhibitors in combating different cancer indications. Notably, the company has ceased the development of inecalcitol, a vitamin D receptor agonist.

Tower Semiconductor Ltd., operating under the brand name TowerJazz, is a global leader in specialty foundry services for semiconductor manufacturing. The company, along with its subsidiaries Jazz Semiconductor Inc. in the U.S. and TowerJazz Japan, Ltd., focuses on producing integrated circuits through a variety of customizable process technologies, including SiGe, BiCMOS, Mixed-Signal/CMOS, RFCMOS, CMOS Image Sensors, Power Management (BCD), and MEMS. TowerJazz supports a rapid and precise design cycle with its design enablement platform and offers Technology Optimization Process Services (TOPS) for integrated device manufacturers (IDMs) and fabless companies seeking to expand their production capacity. The company operates multiple fabrication facilities, located in Israel, the U.S., and Japan, providing clients with multi-fab sourcing options to meet diverse manufacturing needs.

VeriTeQ is a technology company based in Delray Beach, Florida, specializing in identification solutions for animals and emergencies. Founded in 1993, the company offers a range of products including FDA-approved implantable microchips for pet identification, visual and radio frequency identification (RFID) ear tags for livestock tracking, and GPS search and rescue beacons designed for use on aircraft, ships, and by outdoor enthusiasts. Additionally, VeriTeQ develops RFID technologies for identifying implantable medical devices utilized in radiation therapy and is creating a data analytics platform aimed at enhancing evidence-based healthcare through the collection of treatment regimen data.

Luminar Technologies, Inc. is a vehicle sensor and software company based in Orlando, Florida, founded in 2012. The company operates primarily in two segments: Autonomy Solutions and Other Component Sales. The Autonomy Solutions segment focuses on the design, manufacture, and sale of lidar sensors and related perception and autonomy software for original equipment manufacturers in the automotive and commercial vehicle sectors, including applications in robo-taxis. In addition, Luminar's Other Component Sales segment provides design, testing, and consulting services for non-standard integrated circuits aimed at government agencies and defense contractors. The company emphasizes enhancing safety and advancing autonomous technology in vehicles, particularly through advanced driver assistance systems that cater to a range of driving scenarios.